Atropine Sulfate Injection USP, 1 mg/0.7 mL

FDA Drug Profile

Drug Details

Generic Name
Atropine Sulfate Injection USP, 1 mg/0.7 mL
Brand Names
N/A
Application Number
Sponsor
Rafa Laboratories, Ltd.
NDC Codes
1
Dosage Forms
INJECTION
Routes
INTRAMUSCULAR
Active Ingredients
ATROPINE

Indications and Usage

Atropine is indicated for the treatment of poisoning by susceptible organophosphorus nerve agents having anticholinesterase activity as well as organophosphorus or carbamate insecticides in adults and pediatric patients weighing more than 41 kg (90 pounds). Atropine, a cholinergic muscarinic antagonist, is indicated for the treatment of poisoning by susceptible organophosphorus nerve agents having anticholinesterase activity as well as organophosphorus or carbamate insecticides in adults and pediatric patients weighing more than 41 kg (90 pounds) (1).